These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34375646)

  • 21. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
    Gerber BL; Vanoverschelde JL; Bol A; Michel C; Labar D; Wijns W; Melin JA
    Circulation; 1996 Aug; 94(4):651-9. PubMed ID: 8772684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
    Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions among glucose delivery, transport, and phosphorylation that underlie skeletal muscle insulin resistance in obesity and type 2 Diabetes: studies with dynamic PET imaging.
    Goodpaster BH; Bertoldo A; Ng JM; Azuma K; Pencek RR; Kelley C; Price JC; Cobelli C; Kelley DE
    Diabetes; 2014 Mar; 63(3):1058-68. PubMed ID: 24222345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging.
    Farhad H; Dunet V; Bachelard K; Allenbach G; Kaufmann PA; Prior JO
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1203-10. PubMed ID: 23660750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease.
    Tio RA; Dabeshlim A; Siebelink HM; de Sutter J; Hillege HL; Zeebregts CJ; Dierckx RA; van Veldhuisen DJ; Zijlstra F; Slart RH
    J Nucl Med; 2009 Feb; 50(2):214-9. PubMed ID: 19164219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial scar and insulin resistance predict cardiovascular events in severe ischaemic myocardial dysfunction: a perfusion-metabolism positron emission tomography study.
    Feola M; Biggi A; Chauvie S; Vado A; Leonardi G; Rolfo F; Ribichini F
    Nucl Med Commun; 2008 May; 29(5):448-54. PubMed ID: 18391729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve.
    Herzog BA; Husmann L; Valenta I; Gaemperli O; Siegrist PT; Tay FM; Burkhard N; Wyss CA; Kaufmann PA
    J Am Coll Cardiol; 2009 Jul; 54(2):150-6. PubMed ID: 19573732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired skeletal muscle glucose uptake by [18F]fluorodeoxyglucose-positron emission tomography in patients with peripheral artery disease and intermittent claudication.
    Pande RL; Park MA; Perlstein TS; Desai AS; Doyle J; Navarrete N; Copeland-Halperin RS; Redline W; Di Carli MF; Creager MA
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):190-6. PubMed ID: 21051665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance in patients with cardiac hypertrophy.
    Paternostro G; Pagano D; Gnecchi-Ruscone T; Bonser RS; Camici PG
    Cardiovasc Res; 1999 Apr; 42(1):246-53. PubMed ID: 10435017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: application of a new quantitative method using regional tracer kinetic information.
    Wiggers H; Bøttcher M; Nielsen TT; Gjedde A; Bøtker HE
    J Nucl Med; 1999 Aug; 40(8):1292-300. PubMed ID: 10450680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of Myocardial Blood Flow Estimation From Dynamic Contrast-Enhanced Cardiac CT Compared With PET.
    Alessio AM; Bindschadler M; Busey JM; Shuman WP; Caldwell JH; Branch KR
    Circ Cardiovasc Imaging; 2019 Jun; 12(6):e008323. PubMed ID: 31195817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.
    Schöder H; Campisi R; Ohtake T; Hoh CK; Moon DH; Czernin J; Schelbert HR
    J Am Coll Cardiol; 1999 Apr; 33(5):1328-37. PubMed ID: 10193735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes.
    Williams KV; Bertoldo A; Kinahan P; Cobelli C; Kelley DE
    Diabetes; 2003 Jul; 52(7):1619-26. PubMed ID: 12829624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
    Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
    Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction.
    Tsai SY; Wu YW; Wang SY; Shiau YC; Chiu KM; Tsai HY; Lee CL; Hsu JC; Tu CM; Lin HH; Huang SH
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2601-2609. PubMed ID: 31410543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
    J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low whole-body insulin sensitivity in patients with ischaemic heart disease is associated with impaired myocardial glucose uptake predictive of poor outcome after revascularisation.
    Kofoed KF; Carstensen S; Hove JD; Freiberg J; Bangsgaard R; Holm S; Rabøl A; Hesse B; Arendrup H; Kelbaek H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):991-8. PubMed ID: 12173011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease.
    Mäki M; Nuutila P; Laine H; Voipio-Pulkki LM; Haaparanta M; Solin O; Knuuti JM
    Diabetes; 1997 Sep; 46(9):1491-6. PubMed ID: 9287051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18F-fluorodeoxyglucose-PET: a pilot study.
    Soares J; Rodrigues Filho F; Izaki M; Giorgi MC; Catapirra RM; Abe R; Vinagre CG; Cerri GG; Meneghetti JC
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):415-23. PubMed ID: 24253855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.